Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstrasse 400, 01328, Dresden, Germany.
Anorganisch-Chemisches Institut INF 270, Universität Heidelberg, 69120, Heidelberg, Germany.
Chemistry. 2020 Feb 11;26(9):1989-2001. doi: 10.1002/chem.201904654. Epub 2020 Jan 9.
Bifunctional chelators as parts of modular metal-based radiopharmaceuticals are responsible for stable complexation of the radiometal ion and for covalent linkage between the complex and the targeting vector. To avoid loss of complex stability, the bioconjugation strategy should not interfere with the radiometal chelation by occupying coordinating groups. The C9 position of the very stable Cu chelator 3,7-diazabicyclo[3.3.1]nonane (bispidine) is virtually predestined to introduce functional groups for facile bioconjugation as this functionalisation does not disturb the metal binding centre. We describe the preparation and characterisation of a set of novel bispidine derivatives equipped with suitable functional groups for diverse bioconjugation reactions, including common amine coupling strategies (bispidine-isothiocyanate) and the Cu-free strain-promoted alkyne-azide cycloaddition. We demonstrate their functionality and versatility in an exemplary way by conjugation to an antibody-based biomolecule and validate the obtained conjugate in vitro and in vivo.
双功能螯合剂作为模块化基于金属的放射性药物的一部分,负责稳定的放射性金属离子的络合以及络合物与靶向载体之间的共价连接。为了避免络合物稳定性的损失,生物偶联策略不应通过占据配位基团来干扰放射性金属螯合。非常稳定的铜螯合剂 3,7-二氮杂双环[3.3.1]壬烷(双吡啶)的 C9 位几乎是为引入用于简便生物偶联的官能团而设计的,因为这种官能化不会干扰金属结合中心。我们描述了一系列新型双吡啶衍生物的制备和表征,这些衍生物具有适合各种生物偶联反应的官能团,包括常见的胺偶联策略(双吡啶异硫氰酸酯)和无铜应变促进的炔烃-叠氮化物环加成反应。我们通过与基于抗体的生物分子的偶联以示例的方式证明了它们的功能和多功能性,并在体外和体内验证了获得的缀合物。